Table 1.
Clinico-demographic profile of the study participants.
| Parameters | Control Subjects (n = 86) |
Cases (Ovarian Cancer) (n = 83) |
|---|---|---|
| Age (in Years) | 59 ± 3.4 | 58 ± 4.1 |
| Socioeconomic Status n (%) | ||
| Low | 41 (48%) | 45 (54%) |
| Middle | 45 (52%) | 38 (46%) |
| Family history of cancer n (%) | ||
| Yes | 07 (8%) | 24 (29%) * |
| No | 79 (92%) | 59 (71%) |
| Menopausal status n (%) | ||
| Postmenopausal | 47 (55%) | 44 (53%) |
| Premenopausal | 39 (45%) | 39 (47%) |
| Parity n (%) | ||
| Multiparous | 53 (62%) | 67 (81%) * |
| Uniparous | 33 (38%) | 16 (19%) |
| History of PCOD n (%) | ||
| Yes | 02 (2%) | 31 (37%) * |
| No | 84 (98%) | 52 (63%) |
| History of intake of hormone replacement therapy n (%) | NA | |
| Yes | 22 (27%) | |
| No | 61 (73%) | |
| FIGO staging n (%) | NA | |
| Stage II | 15 (18%) | |
| Stage III | 22 (27%) | |
| Stage IV | 46 (55%) |
Data presented as mean ± SD or n (%), NA = Not applicable. * indicates p < 0.05.